These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 17311336
1. Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. Gibb R, Nimmo GR, O'Loughlin P, Lowe P, Drummond D. J Med Virol; 2007 Apr; 79(4):351-5. PubMed ID: 17311336 [Abstract] [Full Text] [Related]
2. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. La'ulu SL, Roberts WL. Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377 [Abstract] [Full Text] [Related]
3. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B. Clin Lab; 2004 May; 50(1-2):63-73. PubMed ID: 15000222 [Abstract] [Full Text] [Related]
4. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays. Louisirirotchanakul S, Khupulsup K, Akraekthalin S, Chan KP, Saw S, Aw TC, Cho DH, Shin MG, Lim J. J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717 [Abstract] [Full Text] [Related]
5. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Clin Lab; 2004 May; 50(3-4):159-62. PubMed ID: 15074469 [Abstract] [Full Text] [Related]
6. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg). Lou SC, Pearce SK, Lukaszewska TX, Taylor RE, Williams GT, Leary TP. J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654 [Abstract] [Full Text] [Related]
7. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. Taylor P, Pickard G, Gammie A, Atkins M. J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762 [Abstract] [Full Text] [Related]
8. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems. Lunel-Fabiani F, Duburcq X, Levayer T, Descamps F, Maniez-Montreuil M, Pivert A, Ducancelle A, Pouzet A, Marant L, Clèment A, Duhamel D, Leirens Y, Margotteau F, Falcou-Briatte R, Heinen C, Bouniort F, Taskar S, Artus A, Woodrum D, Flecheux O. Clin Lab; 2010 Apr; 56(7-8):281-90. PubMed ID: 20857892 [Abstract] [Full Text] [Related]
9. Detection of HBsAg mutants. Osiowy C. J Med Virol; 2006 Apr; 78 Suppl 1():S48-51. PubMed ID: 16622877 [Abstract] [Full Text] [Related]
10. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays. van Helden J, Cornely C, Dati F, Levy HR, Bal T, Seeger M, Wright T, Baker L. J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392 [Abstract] [Full Text] [Related]
11. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan. Mizuochi T, Okada Y, Umemori K, Mizusawa S, Sato S, Yamaguchi K. Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285 [Abstract] [Full Text] [Related]
12. European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants. Avellón A, Echevarría JM, Weber B, Weik M, Schobel U, Willems WR, Gerlich WH. J Med Virol; 2011 Jan; 83(1):95-100. PubMed ID: 21108344 [Abstract] [Full Text] [Related]
13. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. Dati F, Denoyel G, van Helden J. J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761 [Abstract] [Full Text] [Related]
14. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. Weber B, Van der Taelem-Brulé N, Berger A, Simon F, Geudin M, Ritter J. J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005 [Abstract] [Full Text] [Related]
15. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers. Chen D, Kaplan L, Liu Q. Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476 [Abstract] [Full Text] [Related]
16. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay. Echevarría JM, Avellón A. J Med Virol; 2008 Apr; 80(4):598-602. PubMed ID: 18297712 [Abstract] [Full Text] [Related]
17. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection. Matsubara N, Kusano O, Sugamata Y, Itoh T, Mizuii M, Tanaka J, Yoshizawa H. Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255 [Abstract] [Full Text] [Related]
18. Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA. Pfeifer K, Dobson C, Herron A, Kapprell HP. Clin Lab; 2002 Mar; 48(7-8):359-64. PubMed ID: 12146568 [Abstract] [Full Text] [Related]
19. Surveillance for hepatitis B surface antigen mutants. Coleman PF. J Med Virol; 2006 Mar; 78 Suppl 1():S56-8. PubMed ID: 16622879 [Abstract] [Full Text] [Related]
20. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. J Clin Microbiol; 2006 Jul; 44(7):2321-6. PubMed ID: 16825343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]